BAG3 and cerebral cavernous malformation: For BAG3 (rs2234962-C), a significant association with reduced CCM risk was observed in male survivors (n = 3074; OR, 0.69; 95% CI, 0.53-0.91; P = .007), while no significant result was found in female survivors (n = 3103).